NCT02123953View on ClinicalTrials.gov

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TAK-438 in Healthy Male Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions
Dose Finding Study
Interventions
DRUG

TAK-438

TAK-438 tablets

DRUG

TAK-438 Placebo

TAK-438 placebo-matching tablets

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY

NCT02123953 - Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TAK-438 in Healthy Male Participants | Biotech Hunter | Biotech Hunter